GlassScriptPhysician profile
Mark T Tawil
NPI 1285620179
$4,044.17
in general payments reported to CMS, 2019-2025
45 companies · $567 in 2025
The $567 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $475 · 2020: $253 · 2021: $309 · 2022: $1,286 · 2023: $602 · 2024: $552 · 2025: $567.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,721.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,721.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $822.34 | 2019-2025 | Synergy Ablation System, Atriclip Laa Exclusion System |
| Medtronic, INC. | $549.90 | 2022-2025 | Corevalve Evolut R |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $384.64 | 2019-2024 | Lifevest |
| Pfizer INC. | $227.29 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $183.83 | 2019-2025 | Jardiance |
| Amgen INC. | $151.63 | 2019-2025 | Repatha, Repatha |
| Abiomed | $142.94 | 2019-2025 | |
| Boston Scientific Corporation | $136.64 | 2020-2023 | |
| Novartis Pharmaceuticals Corporation | $112.18 | 2022-2025 | |
| Novo Nordisk INC | $89.90 | 2024-2025 | Wegovy |
| Amarin Pharma, INC. | $82.21 | 2019 | |
| Janssen Pharmaceuticals, INC | $73.87 | 2019-2024 | Xarelto |
| Actelion Pharmaceuticals US, INC. | $71.42 | 2020-2025 | Uptravi |
| Medistim USA, INC. | $59.61 | 2024 | Miraq |
| Lemaitre Vascular, INC. | $58.64 | 2022-2025 | Restoreflow, Trivex System |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $55.79 | 2019-2023 | Cardiomems |
| United Therapeutics Corporation | $53.29 | 2023 | |
| Lexicon Pharmaceuticals, INC. | $49.79 | 2023-2024 | Inpefa |
| Medtronic Vascular, INC. | $47.85 | 2019-2020 | |
| Edwards Lifesciences Corporation | $47.13 | 2020 | |
| Intuitive Surgical, INC. | $44.15 | 2023 | Da Vinci Surgical System |
| Lsi Solutions INC | $43.84 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $39.68 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $38.85 | 2019-2024 | |
| Esperion Therapeutics, INC. | $36.40 | 2021 | |
| Philips North America LLC | $34.69 | 2024-2025 | Extended Holter, (Ck4) Mcot |
| E.R. Squibb & Sons, L.L.C. | $34.24 | 2020-2024 | Camzyos |
| Genzyme Corporation | $33.57 | 2023 | |
| Kls-Martin L.P. | $29.18 | 2020-2023 | |
| Cvrx, INC. | $29.06 | 2023 | Barostim Neo System |
| Kiniksa Pharmaceuticals International, Plc | $26.11 | 2024 | Arcalyst |
| Lilly USA, LLC | $25.94 | 2019-2020 | |
| Bard Peripheral Vascular, INC. | $24.86 | 2025 | Rotarexs 6 F X 135 Cm |
| Depuy Synthes Sales INC. | $24.83 | 2024 | Matrixrib |
| Heartflow, INC. | $24.13 | 2025 | |
| Becton, Dickinson and Company | $22.89 | 2024 | Arista Ah Flexitip |
| Stryker Corporation | $20.88 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Merck Sharp & Dohme LLC | $18.56 | 2025 | Verquvo |
| Alnylam Pharmaceuticals INC. | $18.51 | 2024 | Onpattro |
| W. L. Gore & Associates, INC. | $18.30 | 2024 | Gore Viabahn Vbx Balloon Expandable Endo |
| Astellas Pharma US INC | $15.36 | 2019 | |
| Baxter Healthcare | $14.14 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Regeneron Healthcare Solutions, INC. | $12.20 | 2019 | |
| Z-Medica, LLC | $7.09 | 2019 | |
| Vivaquant INC, Dba Rhythm Express | $5.82 | 2025 | Rhythm Express |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Tawil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.